Reference | Study type | Sample | Intervention | Results |
[72] | Randomized clinical trial | · n = 144 with moderate or severe NAFLD · Age: >30 to <60 years · BMI: ≥25 kg/m2 | Low GI Mediterranean diet with aerobic activity program | Reduced NAFLD scores after 45 days of treatment |
[70] | Observational | · n = 54, suffering from metabolic dysfunctions · Age: 53 ± 10 years · BMI: 32 ± 5 kg/m2 | Low GI Mediterranean diet and low-intensity aerobic exercises, accompanied by easy to perform strengthening exercises | · Statistically significant direct effect on BMI · Statistically significant direct effect on Homeostatic Model Assessment for Insulin Resistance or HOMA-IR · Improved status of metabolic-associated fatty liver disease |
[12] | Randomized controlled trial | · n = 63 with metabolic-associated fatty liver disease · Age: 39.3 ± 8.9 years | High protein and low GI diet for 12 weeks | · Loss in body weight · Reduced body fat percentage · Improved visceral fat and blood glucose-related indicators |
[13] | Meta-analysis | n = 2002, having either obesity, diabetes, metabolic syndrome or cardiovascular disease | Low GI diet | · Reduced BMI (p < 0.05) · Improved BMI after interventions of >24 weeks · Controlled fasting blood glucose and HbA1c |
[74] | Randomized controlled parallel trial | · n = 20 with T2DM · Age: 42.4 ± 5.1 years · BMI: 29.2 ± 4.8 kg/m2 | Low GI test meals (breakfast and afternoon) | · Reduced body fat · Reduced negative metabolic and inflammatory responses |
[78] | Systematic review and meta-analysis | n = 1617 with type 1 and 2 diabetes | Low GI/glycemic load diet | · Reduced HbA1c, fasting glucose, triglycerides, body weight and BMI · Improved glycemic control, blood lipids, adiposity, and inflammation beyond concurrent pharmacotherapy |